These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. A Methyltransferase-Defective Vesicular Stomatitis Virus-Based SARS-CoV-2 Vaccine Candidate Provides Complete Protection against SARS-CoV-2 Infection in Hamsters. Lu M; Zhang Y; Dravid P; Li A; Zeng C; Kc M; Trivedi S; Sharma H; Chaiwatpongsakorn S; Zani A; Kenney A; Cai C; Ye C; Liang X; Qiu J; Martinez-Sobrido L; Yount JS; Boyaka PN; Liu SL; Peeples ME; Kapoor A; Li J J Virol; 2021 Sep; 95(20):e0059221. PubMed ID: 34379509 [TBL] [Abstract][Full Text] [Related]
4. Characterization of the SARS-CoV-2 BA.5.5 and BQ.1.1 Omicron variants in mice and hamsters. Case JB; Scheaffer SM; Darling TL; Bricker TL; Adams LJ; Harastani HH; Trende R; Sanapala S; Fremont DH; Boon ACM; Diamond MS J Virol; 2023 Sep; 97(9):e0062823. PubMed ID: 37676002 [TBL] [Abstract][Full Text] [Related]
5. Hamsters Protected from SARS-CoV-2 Delta Variant Challenge after Two Doses of Adjuvanted SARS-CoV-2 Recombinant Spike Protein (S-2P) and One Dose of Beta S-2P. Kuo TY; Lien CE; Lin YJ; Lin MY; Wu CC; Tang WH; Campbell JD; Traquina P; Chuang YS; Liu LT; Cheng J; Chen C J Infect Dis; 2022 Nov; 226(9):1562-1567. PubMed ID: 35451470 [TBL] [Abstract][Full Text] [Related]
6. Immunization with Recombinant Accessory Protein-Deficient SARS-CoV-2 Protects against Lethal Challenge and Viral Transmission. Ye C; Park JG; Chiem K; Dravid P; Allué-Guardia A; Garcia-Vilanova A; Pino Tamayo P; Shivanna V; Kapoor A; Walter MR; Kobie JJ; Plemper RK; Torrelles JB; Martinez-Sobrido L Microbiol Spectr; 2023 Jun; 11(3):e0065323. PubMed ID: 37191507 [TBL] [Abstract][Full Text] [Related]
7. Comparison of the pathogenesis of SARS-CoV-2 infection in K18-hACE2 mouse and Syrian golden hamster models. Jeong H; Woo Lee Y; Park IH; Noh H; Kim SH; Kim J; Jeon D; Jang HJ; Oh J; On D; Uhm C; Cho K; Oh H; Yoon S; Seo JS; Kim JJ; Seok SH; Lee YJ; Hong SM; An SH; Yeon Kim S; Kim YB; Hwang JY; Lee HJ; Kim HB; Jeong DG; Song D; Song M; Park MS; Choi KS; Park JW; Seo JY; Yun JW; Shin JS; Lee HY; Nam KT; Seong JK Dis Model Mech; 2022 Nov; 15(11):. PubMed ID: 36222118 [TBL] [Abstract][Full Text] [Related]
8. The E484K Substitution in a SARS-CoV-2 Spike Protein Subunit Vaccine Resulted in Limited Cross-Reactive Neutralizing Antibody Responses in Mice. Hu L; Xu Y; Wu L; Feng J; Zhang L; Tang Y; Zhao X; Mai R; Chen L; Mei L; Tan Y; Du Y; Zhen Y; Su W; Peng T Viruses; 2022 Apr; 14(5):. PubMed ID: 35632595 [TBL] [Abstract][Full Text] [Related]
9. A single intranasal dose of a live-attenuated parainfluenza virus-vectored SARS-CoV-2 vaccine is protective in hamsters. Liu X; Luongo C; Matsuoka Y; Park HS; Santos C; Yang L; Moore IN; Afroz S; Johnson RF; Lafont BAP; Martens C; Best SM; Munster VJ; Hollý J; Yewdell JW; Le Nouën C; Munir S; Buchholz UJ Proc Natl Acad Sci U S A; 2021 Dec; 118(50):. PubMed ID: 34876520 [TBL] [Abstract][Full Text] [Related]
10. A variant-proof SARS-CoV-2 vaccine targeting HR1 domain in S2 subunit of spike protein. Pang W; Lu Y; Zhao YB; Shen F; Fan CF; Wang Q; He WQ; He XY; Li ZK; Chen TT; Yang CX; Li YZ; Xiao SX; Zhao ZJ; Huang XS; Luo RH; Yang LM; Zhang M; Dong XQ; Li MH; Feng XL; Zhou QC; Qu W; Jiang S; Ouyang S; Zheng YT Cell Res; 2022 Dec; 32(12):1068-1085. PubMed ID: 36357786 [TBL] [Abstract][Full Text] [Related]
11. A Heterologous Challenge Rescues the Attenuated Immunogenicity of SARS-CoV-2 Omicron BA.1 Variant in Syrian Hamster Model. Ma J; Liu X; Zhou M; Chen P; Chen R; Wang J; Zhu H; Wu K; Ye J; Zhang Y; Yuan Q; Tang Q; Yuan L; Cheng T; Guan Y; Xia N J Virol; 2023 Feb; 97(2):e0168422. PubMed ID: 36651747 [TBL] [Abstract][Full Text] [Related]
12. CpG-adjuvanted stable prefusion SARS-CoV-2 spike protein protected hamsters from SARS-CoV-2 challenge. Lien CE; Lin YJ; Chen C; Lian WC; Kuo TY; Campbell JD; Traquina P; Lin MY; Liu LT; Chuang YS; Ko HY; Liao CC; Chen YH; Jan JT; Ma HH; Sun CP; Lin YS; Wu PY; Wang YC; Tao MH; Lin YL Sci Rep; 2021 Apr; 11(1):8761. PubMed ID: 33888840 [TBL] [Abstract][Full Text] [Related]
13. A Single Dose of an MVA Vaccine Expressing a Prefusion-Stabilized SARS-CoV-2 Spike Protein Neutralizes Variants of Concern and Protects Mice From a Lethal SARS-CoV-2 Infection. Pérez P; Lázaro-Frías A; Zamora C; Sánchez-Cordón PJ; Astorgano D; Luczkowiak J; Delgado R; Casasnovas JM; Esteban M; García-Arriaza J Front Immunol; 2021; 12():824728. PubMed ID: 35154086 [TBL] [Abstract][Full Text] [Related]
14. One dose of COVID-19 nanoparticle vaccine REVC-128 protects against SARS-CoV-2 challenge at two weeks post-immunization. Gu M; Torres JL; Li Y; Van Ry A; Greenhouse J; Wallace S; Chiang CI; Pessaint L; Jackson AM; Porto M; Kar S; Li Y; Ward AB; Wang Y Emerg Microbes Infect; 2021 Dec; 10(1):2016-2029. PubMed ID: 34651563 [No Abstract] [Full Text] [Related]
15. Preclinical immunogenicity and efficacy of a candidate COVID-19 vaccine based on a vesicular stomatitis virus-SARS-CoV-2 chimera. Espeseth AS; Yuan M; Citron M; Reiserova L; Morrow G; Wilson A; Horton M; Rukhman M; Kinek K; Hou F; Li SL; Li F; Choi Y; Heidecker G; Luo B; Wu G; Zhang L; Strable E; DeStefano J; Secore S; Mukhopadhyay TK; Richardson DD; Sayeed E; Welch LS; Bett AJ; Feinberg MB; Gupta SB; Cooper CL; Parks CL EBioMedicine; 2022 Aug; 82():104203. PubMed ID: 35915046 [TBL] [Abstract][Full Text] [Related]
16. Recombinant measles virus expressing prefusion spike protein stabilized by six rather than two prolines is more efficacious against SARS-CoV-2 infection. Zhang Y; Lu M; Thongpan I; Xu J; Kc M; Dravid P; Trivedi S; Sharma H; Liang X; Kapoor A; Peeples ME; Li J J Med Virol; 2023 Apr; 95(4):e28687. PubMed ID: 36941778 [TBL] [Abstract][Full Text] [Related]
17. A Beta Strain-Based Spike Glycoprotein Vaccine Candidate Induces Broad Neutralization and Protection against SARS-CoV-2 Variants of Concern. Cao L; Guo J; Li H; Ren H; Xiao K; Zhang Y; Zhu S; Song Y; Zhao W; Wu D; Chen Z; Zhang Y; Xia B; Ji T; Yan D; Wang D; Yang Q; Zhou Y; Li X; Hou Z; Xu W Microbiol Spectr; 2023 Feb; 11(2):e0268722. PubMed ID: 36847495 [TBL] [Abstract][Full Text] [Related]
18. Single MVA-SARS-2-ST/N Vaccination Rapidly Protects K18-hACE2 Mice against a Lethal SARS-CoV-2 Challenge Infection. Clever S; Limpinsel L; Meyer Zu Natrup C; Schünemann LM; Beythien G; Rosiak M; Hülskötter K; Gregor KM; Tuchel T; Kalodimou G; Freudenstein A; Kumar S; Baumgärtner W; Sutter G; Tscherne A; Volz A Viruses; 2024 Mar; 16(3):. PubMed ID: 38543782 [TBL] [Abstract][Full Text] [Related]
19. Live-attenuated pediatric parainfluenza vaccine expressing 6P-stabilized SARS-CoV-2 spike protein is protective against SARS-CoV-2 variants in hamsters. Liu X; Park HS; Matsuoka Y; Santos C; Yang L; Luongo C; Moore IN; Johnson RF; Garza NL; Zhang P; Lusso P; Best SM; Buchholz UJ; Le Nouën C PLoS Pathog; 2023 Jun; 19(6):e1011057. PubMed ID: 37352333 [TBL] [Abstract][Full Text] [Related]
20. Subunit vaccine raised against the SARS-CoV-2 spike of Delta and Omicron variants. Feng S; Fan Z; Zhou K; Ma S; Liang M; Zhang H; Xie Y; Ha Z; Jin N; Lu H J Med Virol; 2023 Oct; 95(10):e29160. PubMed ID: 37822266 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]